C12N 2770/40061
Methods of inactivation or attenuation
C12N2770/40061 (Methods of inactivation or attenuation) appears on 4 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 5
- Assignees
- 2
- Inventors
- 18
- Latest grant
- 24 Dec 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 1 | 1 |
| 2024 | 1 | 0 |
By publication year.
Subgroups
Granted patents
Recent patents
- Virus and antigen conjugation24 Dec 2024US 12,173,328 B2Kbio Holdings Limited
- Antigen purification23 May 2023US 11,655,461 B2Kbio Holdings Limited
- Virus and antigen purification and conjugation1 Nov 2022US 11,485,956 B2Kbio Holdings Limited
- Virus purification3 Nov 2020US 10,822,591 B2Kentucky BioProcessing, Inc.
- Virus and antigen conjugation26 Jan 2023US 2023/0027693 A1Kbio Holdings Limited
- Antigen purification21 Jan 2021US 2021/0017502 A1Kentucky BioProcessing, Inc.
- Virus and antigen purification and conjugation12 Dec 2019US 2019/0374616 A1Kbio Holdings Limited
- Virus and antigen purification and conjugation12 Dec 2019US 2019/0376049 A1Kentucky BioProcessing, Inc.
- Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes12 Sep 2013US 2013/0236491 A1
Most cited
By later US patents